These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 9790357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, Wendel GD.
    Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
    [Abstract] [Full Text] [Related]

  • 3. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK, Douglas JM, Corey L, Spruance SL, Esmann J.
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [Abstract] [Full Text] [Related]

  • 4. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK, Baker D, Snowden W.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [Abstract] [Full Text] [Related]

  • 5. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
    Bras AP, Sitar DS, Aoki FY.
    Can J Clin Pharmacol; 2001 Oct 15; 8(4):207-11. PubMed ID: 11743593
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O.
    Cochrane Database Syst Rev; 2014 Aug 03; 2014(8):CD009036. PubMed ID: 25086573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH, Warren T, Werner M, Phillips JA.
    Sex Transm Dis; 2007 Jun 03; 34(6):339-43. PubMed ID: 17065847
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Valacyclovir in the treatment of genital herpes and herpes zoster.
    Baker DA.
    Expert Opin Pharmacother; 2002 Jan 03; 3(1):51-8. PubMed ID: 11772333
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M, Tyring S, Koltun W, Bodsworth N, Hamed K.
    Clin Infect Dis; 2008 Sep 01; 47(5):651-8. PubMed ID: 18637755
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
    Frenkel LM, Brown ZA, Bryson YJ, Corey L, Unadkat JD, Hensleigh PA, Arvin AM, Prober CG, Connor JD.
    Am J Obstet Gynecol; 1991 Feb 01; 164(2):569-76. PubMed ID: 1847004
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.